Michael Centola
Overview
Explore the profile of Michael Centola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan X, Li F, Dozmorov I, Frank M, Dao M, Centola M, et al.
Mol Cell Biochem
. 2024 Sep;
480(3):1933.
PMID: 39327376
No abstract available.
2.
Bathon J, Centola M, Liu X, Jin Z, Ji W, Knowlton N, et al.
Arthritis Res Ther
. 2023 Oct;
25(1):213.
PMID: 37899440
Background: Cardiovascular (CV) risk estimation calculators for the general population underperform in patients with rheumatoid arthritis (RA). The purpose of this study was to identify relevant protein biomarkers that could...
3.
Taylor H, Hale J, Centola M, Blodgett A
IEEE Open J Eng Med Biol
. 2023 Feb;
3:167-170.
PMID: 36846360
A key aspect of the National Institutes of Health (NIH) funded Rapid Acceleration of Diagnostics (RADx) Tech program was an active Clinical Studies Core including Committees with unique expertise to...
4.
Bastin B, Horine L, Bird P, Benzinger M, Agin J, Goins D, et al.
J AOAC Int
. 2020 Nov;
102(5):1455-1471.
PMID: 33216925
Background: The Polyskope 1.0 Multiplex Assay is a novel test to simultaneously detect Escherichia coli O157, non-O157 Shiga Toxin-Producing E. coli (STEC), Listeria monocytogenes, and Salmonella species in a single...
5.
Kishi T, Chipman J, Evereklian M, Nghiem K, Stetler-Stevenson M, Rick M, et al.
J Rheumatol
. 2019 Aug;
47(7):1011-1018.
PMID: 31371656
Objective: Circulating endothelial cells (CEC), von Willebrand factor (vWF) antigen, P-selectin, and thrombomodulin are released from damaged endothelium, while decreases in circulating endothelial progenitor cells (CEPC) have been associated with...
6.
Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan K, et al.
PLoS One
. 2013 Apr;
8(4):e60635.
PMID: 23585841
Background: Disease activity measurement is a key component of rheumatoid arthritis (RA) management. Biomarkers that capture the complex and heterogeneous biology of RA have the potential to complement clinical disease...
7.
Du M, Basu A, Fu D, Wu M, Centola M, Jenkins A, et al.
Diabetes Care
. 2013 Feb;
36(7):2054-61.
PMID: 23393212
Objective: Inflammation and endothelial dysfunction have been associated with the immunobiology of preeclampsia (PE), a significant cause of adverse pregnancy outcomes. The prevalence of PE is elevated several fold in...
8.
Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems W, et al.
Rheumatology (Oxford)
. 2013 Feb;
52(7):1202-7.
PMID: 23392591
Objective: To evaluate a multi-biomarker disease activity (MBDA) score, a novel index based on 12 serum proteins, as a tool to guide management of RA patients. Methods: A total of...
9.
Curtis J, van der Helm-van Mil A, Knevel R, Huizinga T, Haney D, Shen Y, et al.
Arthritis Care Res (Hoboken)
. 2012 Jun;
64(12):1794-803.
PMID: 22736476
Objective: Quantitative assessment of disease activity in rheumatoid arthritis (RA) is important for patient management, and additional objective information may aid rheumatologists in clinical decision making. We validated a recently...
10.
Bakker M, Cavet G, Jacobs J, Bijlsma J, Haney D, Shen Y, et al.
Ann Rheum Dis
. 2012 May;
71(10):1692-7.
PMID: 22596166
Objectives: To evaluate the performance of individual biomarkers and a multi-biomarker disease activity (MBDA) score in the early rheumatoid arthritis (RA) patient population from the computer assisted management in early...